Author

H.-J. Senn

Observed names: H -J Senn, H J Senn, H. J. Senn, H. Senn, H.-J Senn, H.J. Senn, HJ Senn, Hans-J�rg Senn

Institution: St. Gallen Oncology Conferences

Observed institutions: University of Bern, University of Freiburg, University of Basel, Kantonsspital St. Gallen, University Medical Center Freiburg, Jewish General Hospital, Groote Schuur Hospital, Hôpital du Saint-Sacrement, St. Gallen Oncology Conferences, Tumor- und Brustzentrum ZeTuP Silberturm, Swiss Group For Clinical Cancer Research, International Breast Cancer Study Group, Cross Cancer Institute

OpenAlex ID: A5111738720

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

2015 · A.S. Coates, E.P. Winer, et al. · Annals of Oncology · 1,862

PDF

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

2021 · H.J. Burstein, G. Curigliano, et al. · Annals of Oncology · 875

PDF

Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

2019 · H.J. Burstein, G. Curigliano, et al. · Annals of Oncology · 689

PDF

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

1999 · J.-M. Nabholtz, H. J. Senn, et al. · Journal of Clinical Oncology · 507

Estimates of benefits and harms of prophylactic use of aspirin in the general population

2014 · J. Cuzick, M.A. Thorat, et al. · Annals of Oncology · 387

PDF

The process of metastasisation for breast cancer

2003 · J. Engel, R. Eckel, et al. · European Journal of Cancer · 162

First—select the target: better choice of adjuvant treatments for breast cancer patients

2006 · A. Goldhirsch, A.S. Coates, et al. · Annals of Oncology · 97

Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment

2006 · A. Glaus, Ch. Boehme, et al. · Annals of Oncology · 94

PDF

Interferon-alpha for induction and maintenance in multiple myeloma: Results of two multicenter randomized trials and summary of other studies

1995 · H. Ludwig, A.M. Cohen, et al. · Annals of Oncology · 87

Combined chemo- and hormonal therapy in advanced breast cancer

1977 · K. W. Brunner, R. W. Sonntag, et al. · Cancer · 74

PDF

International consensus panel on the treatment of primary breast cancer

1995 · A. Goldhirsch, W.C. Wood, et al. · European Journal of Cancer · 73

Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

2018 · G. Curigliano, H.J. Burstein, et al. · Annals of Oncology · 54

Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype

1994 · B. Nathan, B. Gusterson, et al. · Annals of Oncology · 49

?Fatigue and malaise? as a quality-of-life indicator in small-cell lung cancer patients

1993 · Christoph H�rny, J�rg Bernhard, et al. · Supportive Care in Cancer · 48

Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer

2003 · H.-J Senn, B Thürlimann, et al. · The Breast · 42

Pamidronate treatment in patients with malignant osteolytic bone disease and pain

1999 · D. Koeberle, L. Bacchus, et al. · Supportive Care in Cancer · 40

Routine tests during follow-up of patients after primary treatment for operable breast cancer

1995 · D. Crivellari, K.N. Price, et al. · Annals of Oncology · 30

Second Malignant Neoplasms in Operable Carcinoma of the Breast

1984 · E. E. Holdener, R. Nissen-Meyer, et al. · Recent results in cancer research/Recent Results in Cancer Research · 27

Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: Its effect on patient self-estimation

1994 · C. Hūirny, J. Bernhard, et al. · Annals of Oncology · 25

PDF

Human Monocytopoiesis in Acute and Chronic Inflammation

2009 · G. Meuret, U. Detel, et al. · Acta Haematologica · 20

Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy

1997 · M Castiglione-Gertsch, M Tattersall, et al. · European Journal of Cancer · 19

BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer

2001 · F Schoumacher, A Glaus, et al. · Swiss Medical Weekly · 18

Limitations of the salmonella/mammalian microsome assay (AMES test) to determine occupational exposure to cytostatic drugs

1986 · U. Friederich, F. Molko, et al. · European Journal of Cancer and Clinical Oncology · 17

Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients

1999 · M. E. E. Sabbioni, Monica Castiglione, et al. · Supportive Care in Cancer · 14

Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.

1997 · H J Senn, R Maibach, et al. · Journal of Clinical Oncology · 11

Works count: 73

Citation count: 5,419

H-index: 20

I10-index: 27